Dr. Mclendon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
MSRB RM 181
Research Dr
Durham, NC 27705Phone+1 919-684-8111
Summary
- Dr. Roger Mclendon is a pathologist in Durham, NC and is affiliated with Duke University Hospital. He received his medical degree from Medical College of Georgia School of Medicine and has been in practice 34 years. He specializes in neuropathology and anatomic pathology and is experienced in molecular biology, neuropathology, and forensic / autopsy pathology.
Education & Training
- Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1983 - 1987
- Duke University HospitalInternship, Neuropathology, 1983 - 1987
- Medical College of Georgia at Augusta UniversityClass of 1983
- Emory UniversityB.A., 1979
- Oxford College of Emory UniversityA.A., 1977
Certifications & Licensure
- NC State Medical License 1984 - 2025
- GA State Medical License 1987 - 2021
- American Board of Pathology Anatomic Pathology
- American Board of Pathology Neuropathology
Awards, Honors, & Recognition
- Team Science Award American Association of Cancer Research, 2014
- Wiley Forbus Research Award The North Carolina Society of Pathologists, 1987
- Dean's Summer Research Fellowship Medical College of Georgia, 1980
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsCancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells.Heng Liu, Cheng Xu, Bill H Diplas, Alexandrea Brown, Laura M Strickland
Neuro-Oncology. 2023-09-05 - 11 citationsRecombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial.Eric M Thompson, Daniel Landi, Michael C Brown, Henry S Friedman, Roger McLendon
The Lancet. Child & Adolescent Health. 2023-07-01 - 2 citationsCD155 is a putative therapeutic target in medulloblastoma.Sean Li, Roger McLendon, Eric Sankey, Reb Kornahrens, Anne-Marie Lyne
Clinical & Translational Oncology. 2023-03-01
Journal Articles
- Heterogeneity Within the PF-EPN-B Ependymoma SubgroupAndrew Grossbach, Vijay Ramaswamy, Benjamin Lu, Mariarita Santi, Caterina Giannini, Linda M Liau, Terri S Armstrong, Sarah Leary, Matthias A Karajannis, Kenneth Aldape..., Acta Neuropathologica
- The Genomic Landscape of TERT Promoter Wildtype-IDH Wildtype GlioblastomaDaniel B. Loriaux, Darel D. Bigner, Fausto J. Rodriguez, Hai Yan, Bil H. Diplas, Henry S. Friedman, Roger E. McLendon, Nature
- The Utility of Expert Diagnosis in Surgical Neuropathology: Analysis of Consultations Reviewed at 5 National Comprehensive Cancer Network InstitutionsJanet M. Bruner, Roger McLendon, Journal of Neuropathology & Experimental Neurology
- Join now to see all
Books/Book Chapters
Lectures
- Grand Rounds in Medical OncologyChulalongkorn Hospital, Bangkok, Thailand - 1/6/2014
- Diagnostic Issues in NeuropathologySingapore General Hospital, Singapore - 1/2/2014
- Adult Glioma Biomarker Testing - An UpdateBrigham and Women’s Hospital, Boston, MA - 1/31/2013
- Join now to see all
Other
- Pathology of Diffuse AstrocytomasMcLendon RE, Medscape Reference
http://emedicine.medscape.com/article/1780914-overview
1/18/2013 - Pathology of OligodendrogliomasMcLendon RE, Medscape Reference
http://emedicine.medscape.com/article/1743896-overview
1/13/2013 - OligodendrogliomasMcLendon RE, eMedicine from WebMD
http://emedicine.medscape.com/article/1743896-overview
1/17/2010 - Join now to see all
Press Mentions
- The CBTRUS Story: Providing Accurate Population-Based Statistics on Brain and Other Central Nervous System Tumors for EveryoneFebruary 19th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: